Pineoblastoma
What's New
Last Posted: Mar 07, 2023
- Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.
Snuderl Matija, et al. Nature communications 2018 0 (1) 2868 - ATRX Mutations in Pineal Parenchymal Tumors of Intermediate Differentiation.
Martínez Haydee, et al. Journal of neuropathology and experimental neurology 2019 0 (8) 703-8 - Pineal Parenchymal Tumor of Intermediate Differentiation and DICER1 Syndrome: A Case Report.
Gupte Avanti, et al. Journal of pediatric hematology/oncology 2022 0 - Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients.
Miller Alexandra M et al. Neuro-oncology 2022 - CLINGEN Actionability Report for DICER1-Related Disorders-DICER1
ClinGen Actionability Working Group - Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline Cassie N et al. Neuro-oncology 2017 19(5) 699-709 - DICER1 and associated conditions: Identification of at-risk individuals and recommended surveillance strategies.
Schultz Kris Ann P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Jan - DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center.
van Engelen Kalene et al. Pediatric blood & cancer 2017 Sep - PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Schultz Kris Ann P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Jun 23(12) e76-e82 - Germ-line and somatic DICER1 mutations in pineoblastoma.
de Kock Leanne, et al. Acta neuropathologica 2014 10 (4) 583-95
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: